Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA)

BVMT:SIPHA Income Statement

Financials in millions TND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Operating Revenue	17.97	22.51	31.06	35.3	40.78	42.28
Other Revenue	2.25	1.89	2.13	1.99	1.8	2.5
Revenue	20.23	24.4	33.19	37.3	42.58	44.79
Revenue Growth (YoY)	-35.11%	-26.47%	-11.00%	-12.41%	-4.93%	8.82%
Cost of Revenue	11.03	15.38	21.08	20.11	20.09	20.95
Gross Profit	9.19	9.03	12.11	17.19	22.48	23.84
Selling, General & Admin	18.52	18.42	18.29	18.48	19.53	19.74
Other Operating Expenses	3.2	2.74	1.93	1.93	2.59	2.67
Operating Expenses	23.11	22.68	22.15	22.53	24.43	24.99
Operating Income	-13.92	-13.65	-10.04	-5.34	-1.94	-1.16
Interest Expense	-1.96	-1.81	-1.34	-1.01	-0.74	-0.96
Interest & Investment Income	0.01	0.12	0.05	0.03	0.02	0.09
Currency Exchange Gain (Loss)	-1.55	0.77	-1.98	-1.16	-1.59	-0.46
Other Non Operating Income (Expenses)	0.3	0.11	-0.93	-0.06	0.22	0.11
EBT Excluding Unusual Items	-17.12	-14.47	-14.25	-7.54	-4.03	-2.37
Gain (Loss) on Sale of Investments	-	-	-	-0.12	-	-0.43
Gain (Loss) on Sale of Assets	-	-	0.06	-	0.36	0.05
Asset Writedown	0.06	-	-0	-	-	-
Legal Settlements	-	-	-	-	-	0.03
Other Unusual Items	-	-	-	-	-0.01	-0.04
Pretax Income	-17.06	-14.47	-14.2	-7.66	-3.68	-2.75
Income Tax Expense	0.04	0.05	0.07	0.08	0.09	0.09
Earnings From Continuing Operations	-17.1	-14.52	-14.27	-7.73	-3.77	-2.85
Net Income	-17.1	-14.52	-14.27	-7.73	-3.77	-2.85
Net Income to Common	-17.1	-14.52	-14.27	-7.73	-3.77	-2.85
Shares Outstanding (Basic)	2	2	2	2	2	-
Shares Outstanding (Diluted)	2	2	2	2	2	-
EPS (Basic)	-9.50	-8.07	-7.93	-4.30	-2.09	-
EPS (Diluted)	-9.50	-8.07	-7.93	-4.30	-2.09	-
Free Cash Flow	-15.37	-6.77	2.5	-2.95	1.65	3.04
Free Cash Flow Per Share	-8.54	-3.76	1.39	-1.64	0.92	-
Gross Margin	45.45%	36.99%	36.48%	46.08%	52.81%	53.22%
Operating Margin	-68.83%	-55.94%	-30.26%	-14.32%	-4.56%	-2.58%
Profit Margin	-84.57%	-59.52%	-42.98%	-20.74%	-8.85%	-6.35%
Free Cash Flow Margin	-75.99%	-27.73%	7.52%	-7.91%	3.88%	6.80%
EBITDA	-12.53	-12.13	-8.11	-3.22	0.37	1.43
EBITDA Margin	-61.96%	-49.70%	-24.43%	-8.64%	0.86%	3.18%
D&A For EBITDA	1.39	1.52	1.93	2.12	2.31	2.58
EBIT	-13.92	-13.65	-10.04	-5.34	-1.94	-1.16
EBIT Margin	-68.83%	-55.94%	-30.26%	-14.32%	-4.56%	-2.58%
Revenue as Reported	20.27	24.46	33.15	37.37	42.65	44.84
Advertising Expenses	-	0.17	0.36	0.37	0.52	0.62

Updated Feb 22, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.